How can I tell if a weight-loss pen is counterfeit?

MHRA and other regulators have issued public warnings on counterfeit GLP-1 pens, but visual inspection alone cannot reliably distinguish a well-made counterfeit from a genuine product. The only route that guarantees provenance is obtaining the medicine via a qualified UK prescriber and dispensing through a registered UK pharmacy.

What are the risks of buying from an unregulated online source?

Counterfeit and grey-market compounded products may contain incorrect doses, contaminants, or entirely different active ingredients than labelled, with no guarantee of sterility or purity. Because these products fall outside the regulated pharmacovigilance system, adverse events from them are also far harder to track and act on.

What should I do if I suspect I've been sold a counterfeit product?

Any adverse event from a product whose provenance is uncertain warrants urgent qualified clinical assessment rather than self-management. Suspected counterfeit products should also be reported via the MHRA Yellow Card scheme and to the MHRA directly — see the UK-specific guidance on counterfeit weight-loss pens for the reporting routes.

Why does provenance matter even if the product seems to work?

Apparent short-term effect does not confirm correct identity, dose or purity — some counterfeit products have been found to contain the wrong substance entirely, or doses that are inconsistent between units. The absence of regulated pharmacovigilance also means that if something does go wrong, there is far less structured mechanism for it to be identified, investigated and acted on across the wider supply.

Counterfeit and unregulated products

Counterfeit weight-loss pens, mislabelled vials and grey-market compounded products have been the subject of MHRA enforcement and public warnings. Risks include unknown identity, purity, sterility, dosing accuracy and the absence of regulated pharmacovigilance.

What is known

MHRA and other regulators have issued public warnings on counterfeit GLP-1 pens.
Counterfeit and compounded products may contain incorrect doses, contaminants, or different active ingredients altogether.

What remains uncertain

The scale of grey-market exposure within the UK at any given time.

Trial limitations

Counterfeit-product effects are not subject to controlled trials.

FAQs

How can I tell if a weight-loss pen is counterfeit?: MHRA and other regulators have issued public warnings on counterfeit GLP-1 pens, but visual inspection alone cannot reliably distinguish a well-made counterfeit from a genuine product. The only route that guarantees provenance is obtaining the medicine via a qualified UK prescriber and dispensing through a registered UK pharmacy.
What are the risks of buying from an unregulated online source?: Counterfeit and grey-market compounded products may contain incorrect doses, contaminants, or entirely different active ingredients than labelled, with no guarantee of sterility or purity. Because these products fall outside the regulated pharmacovigilance system, adverse events from them are also far harder to track and act on.
What should I do if I suspect I've been sold a counterfeit product?: Any adverse event from a product whose provenance is uncertain warrants urgent qualified clinical assessment rather than self-management. Suspected counterfeit products should also be reported via the MHRA Yellow Card scheme and to the MHRA directly — see the UK-specific guidance on counterfeit weight-loss pens for the reporting routes.
Why does provenance matter even if the product seems to work?: Apparent short-term effect does not confirm correct identity, dose or purity — some counterfeit products have been found to contain the wrong substance entirely, or doses that are inconsistent between units. The absence of regulated pharmacovigilance also means that if something does go wrong, there is far less structured mechanism for it to be identified, investigated and acted on across the wider supply.